drugset / Trial / NCT06969664

A Trial of SHR7280 in Healthy Subjects

NCT06969664

Phase 1 Completed 16 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the effect of high-fat meal on pharmacokinetics of SHR7280 after oral administration and the effect of SHR7280 on QT interval at low and high doses in healthy Chinese volunteers.

Timeline

Start
2025-05-19
Primary completion
2025-07-05
Completion
2025-07-05

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR7280 Small molecule Oral

Indications